Journaling and Weight Loss

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by University of California, Davis.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
University of California, Davis
ClinicalTrials.gov Identifier:
NCT00884195
First received: April 17, 2009
Last updated: May 25, 2011
Last verified: May 2011

April 17, 2009
May 25, 2011
January 2009
September 2011   (final data collection date for primary outcome measure)
Weight loss [ Time Frame: 3 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00884195 on ClinicalTrials.gov Archive Site
  • Quality of Life [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • Class attendance [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Journaling and Weight Loss
Journaling and Weight Loss

This is a pilot study to evaluate the effect of keeping a 'gratitude journal' on the outcome of a weight loss program. All the subjects will be enrolled in the Lifesteps weight management program. The experimental group will maintain a gratitude journal and the control group will maintain a 'neutral' journal.

Subjects who are referred to the Preventive Cardiology Program for weight management will be enrolled in the study after obtaining informed consent.

Subjects are enrolled into the program in groups of 10 to 12 every 6 weeks. Alternate groups will be will assigned to the two types of journaling. Each group will be given specific instructions related to the form of journaling assigned. These instructions will be in addition to the usual care prescribed in the Lifesteps® program. In the intervention group, patients will be introduced to gratitude journaling at the beginning of the 12 week class series and asked to journal each day. They will turn in their gratitude journal weekly. At the beginning of each weekly class, five minutes will be spent discussing the journaling.

The control groups will not receive the information on gratitude journaling, but instead will be asked to complete a neutral journal in which they will journal in a general manner regarding their experiences participating in the Lifesteps® weight management program. These will also be collected weekly. At the beginning of class, five minutes will be spent discussing the journaling.

There will be one consent form for the two groups. The instruction (either gratitude journaling or neutral journaling) that will be given to the subjects will reflect the group to which they have been randomized. Both types of journals will be reviewed initially, at mid-point and final by the psychologist (Robert Emmons) to verify the quality of reporting.

Routine tests- Weekly weights

Study Tests:

Pre/post depression: Beck Depression Inventory II; Pre/post Locus of Control: Multidimensional Health Locus of Control Scale; Pre/post SF 36 Quality of Life Questionnaire; Pre/post Gratitude Questionnaire

Interventional
Phase 1
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Obesity
  • Behavioral: Gratitude Journaling
    Participants will be asked to write down 5 things every day for which they are grateful.
  • Behavioral: Neutral Journaling
    Participants will be asked to write down 5 things every day that they noticed about being involved in a weight loss program.
  • Experimental: 1
    Gratitude Journaling
    Intervention: Behavioral: Gratitude Journaling
  • Placebo Comparator: 2
    Neutral Journaling
    Intervention: Behavioral: Neutral Journaling
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
50
December 2011
September 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • BMI>25
  • >18 years of age

Exclusion Criteria:

  • Severe psychiatric diagnosis which in the opinion of the PI would compromise participation in the study.
  • Addiction to alcohol and drugs
Both
18 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00884195
200816667-1
No
CT Kappagoda, University of California Davis
University of California, Davis
Not Provided
Principal Investigator: CT Kappagoda, MD, PhD University of California, Davis
University of California, Davis
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP